Clinical Trial

Comparison of the Effects of Sacral Erector Spinae Plane Block and Dorsal Penile Block on Postoperative Pain in Circumcision Procedures

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Egypt performed circumcision in 2300 BC, although its origin is unknown. Some societies use circumcision for health, whereas others do it for religious and cultural reasons . Our competent pediatric surgeons perform circumcisions without ultrasonography using midazolam (0.1 mg/kg) premedication and penile block. In addition to penile block, general anesthesia is given using sevoflurane, ketamine, fentanyl, and propofol, depending on age and weight, for intraoperative anesthesia and analgesia. Penis procedures are frequently simple (phimosis, circumcision), but the pain is significant and long-lasting, affecting young patients' postoperative recovery. The topic of analgesia remains relevant and important in anesthesia practice. Early patient mobilization and discharge are crucial. Pediatric opioid use is questioned due to adverse effects include somnolence, vomiting, and respiratory depression. The advent of ultrasound-guided nerve blocks has revolutionized regional anesthesia in pediatrics. Many upper and lower abdominal operations use truncal blocks with good success and patient safety. Since its applicability, ease of anatomical approach, distance to the medulla spinalis and surgical site, and minimal risk of infection, sacral ESP block has become a popular method for youngsters. Postoperative pain trials demonstrate it works well.
Protocol Amendment History 4 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-24
critical Phase changed: not applicable -> not specified 2026-07-24
notable Primary completion pushed: 2025-12-15 -> 2026-07-15 2026-07-24
minor Completion pushed: 2025-12-25 -> 2026-08-25 2026-07-24
Trial Details
NCT Number NCT06843070
Lead Sponsor Konya City Hospital
Conditions Postoperative Analgesia
Enrollment 50 participants
Start Date 2025-02-25
Primary Completion 2026-07-15 (estimated)
Study Completion 2026-08-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-23